Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-004352
Filing Date
2025-01-10
Accepted
2025-01-10 18:07:57
Documents
1
Period of Report
2025-01-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6227
  Complete submission text file 0000950170-25-004352.txt   7723
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Issuer) CIK: 0001937653 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 114 EAST 4TH AVENUE, SUITE 800 VANCOUVER A1 V5T 1G4
Business Address
Moore Paul Andrew (Reporting) CIK: 0001938192 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41535 | Film No.: 25524219